Europe Heart Valve Devices Market - Industry Trends and Forecast to 2030

The heart valve devices market is projected to register a CAGR of 13.4% in the forecast period of 2023 to 2030. The new market report contains data for historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030

Market Segmentation:

Europe Heart Valve Devices Market, By Product Type (Mechanical Heart Valve, Biological Heart Valve And Transcatheter Valve) Treatment (Open Surgery and Minimal Invasive Surgery (MIS)) End User (Hospitals & Clinics, Ambulatory Surgical Centers, Cardiac Centers, Research Centers And Others) Distribution Channel (Direct Tender, Third Party Distributors) Country (Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland and the rest of Europe) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the heart valve devices market are:

• Innovations in heart valve devices offer improved clinical outcome
• Rising number of various heart diseases
Market Players
Some of the major players operating in the heart valve devices market are:
• Abbott
• Boston Scientific Corporation or its affiliates
• Artivion, Inc.
• Edwards Lifesciences Corporation
• Medtronic
• NeoVasc
• Micro Interventional Devices Incorporated
• XELTIS
• TTK
• Meril Life Sciences Pvt. Ltd
• Foldax, Inc.
• Venus Medtech (Hangzhou) Inc.
• Colibri Heart Valve